Indian Pharmaceutical Market Analyzed & Forecast in New Topical Report Published at MarketPublishers.com
08 May 2012 • by Natalie Aster
LONDON – The Indian pharmaceutical market looks poised to grow to USD 14.99 billion in 2012, with a CAGR of 12.96%.
The biopharmaceutical sector, which contributed almost 62% in the Indian biotech industry in 2011, is expected to witness double digit growth led by major developments in therapeutic segment. The vaccines market is enjoying a continuous growth, dominated by human vaccine segment which accounted for more than three fourth of the market. Holding the dominant position in the total pharmaceutical market, the generic drugs segment is expected to grow at a faster rate from 2012 onwards although industry may witness price erosion leading to reduced generic player’s profit margin.
New market research report “India Pharmaceutical Industry Research and Forecast to 2016” drawn up by AM Mindpower Solutions has been recently published at Market Publishers Ltd.
India Pharmaceutical Industry Research and Forecast to 2016
Published: April, 2012
Price: US$ 850,00
The research report offers a comprehensive guide to India’s bulk and formulations market, sub-segmented into OTC, prescription drugs and generic drugs. It analyzes major bio-pharmaceutical market segments, top therapeutic categories and traditional medicine market. The study also includes SWOT analysis, major driving forces, industry challenges & opportunities, regulatory structure, macro economy factors and political environment of the country. In addition, profiles of the top domestic and international players as well as detailed forecasts of the industry and its segments’ growth are also provided.
More new market research reports by the publisher can be found at AM Mindpower Solutions page.